# A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy Volunteers

> **NCT01259882** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 61 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** PF-05089771
- **DRUG:** PF-05089771
- **DRUG:** PF-05089771
- **DRUG:** PF-05089771
- **DRUG:** PF-05089771
- **DRUG:** PF-05089771

## Key facts

- **NCT ID:** NCT01259882
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2012-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01259882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01259882, "A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01259882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*